Zeneca Inc.
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Zeneca Inc.
Generic Hetlioz Does Not Require Braille Labeling, FDA Tells Vanda
FDA says Teva and Apotex’s generic products do not violate the ‘same labeling’ requirement because they were produced by different manufacturers and that braille is not necessary for safe and effective use of tasimelteon products. Vanda's generic labeling suit against the FDA remains pending.
Generic Hetlioz Does Not Require Braille Labeling, FDA Tells Vanda
FDA says Teva and Apotex’s generic products do not violate the ‘same labeling’ requirement because they were produced by different manufacturers and that braille is not necessary for safe and effective use of tasimelteon products. Vanda's generic labeling suit against the FDA remains pending.
Merck/AstraZeneca Stay Tied To Each Other For Another Two Years
Merck and AstraZeneca continue a 30-year partnership after coming to terms that could benefit both companies.
Company Information
- Industry
- Pharmaceuticals
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice